A Study of Valemetostat Tosylate in Combination With DXd ADCs in Subjects With Solid Tumors
Running, not enrolling · Phase 1
Conditions studied: Advanced Solid Tumor
In brief
This study will evaluate the safety, tolerability, and efficacy of valemetostat tosylate in combination with DXd ADC in patients with advanced solid tumors.
Key facts
- Study ID
- NCT06244485
- Run by
- Daiichi Sankyo
- People needed
- 98
- Starts
- 2024-02-16
- Expected to finish
- 2028-11-01
- Last updated by the study team
- 2026-07-21
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- City of Hope At Orange County Lennar Foundation Cancer Center — Irvine, California, United States
- Sharp Memorial Hospital — San Diego, California, United States
- Brcr Medical Center, Inc Dba Boca Raton Clinical Research — Plantation, Florida, United States
- University of Hawaii At Manoa — Honolulu, Hawaii, United States
- University of Chicago Medical Center — Chicago, Illinois, United States
- Dana-Farber Cancer Institute — Boston, Massachusetts, United States
- Memorial Sloan-Kettering Cancer Center (Mskcc) - New York — New York, New York, United States
- Clinical Research Alliance — Westbury, New York, United States
- Unc Hospitals — Chapel Hill, North Carolina, United States
- The Cleveland Clinic Foundation — Cleveland, Ohio, United States
- Providence Portland Medical Center — Portland, Oregon, United States
- Mary Crowley Cancer Research Centers — Dallas, Texas, United States
- Ut Southwestern Medical Center — Dallas, Texas, United States
- University of Texas M. D. Anderson Cancer Center — Houston, Texas, United States
- Next Virginia — Fairfax, Virginia, United States
- Fred Hutchinson Cancer Center — Seattle, Washington, United States
- Medical College of Wisconsin — Milwaukee, Wisconsin, United States
- Peking University Third Hospital — Beijing, China
- Sun Yat-Sen University, Cancer Center — Guangzhou, China
- SunYat-Sen University Cancer Center — Guangzhou, China
- Harbin Medical Univeristy Cancer Hospital — Heilongjiang, China
- Hunan Cancer Hospital — Hunan, China
- Jilin Cancer Hospital — Jilin City, China
- Jinana Center Hosptial — Shandong, China
- IRCCS Istituto Scientifico Romagnolo Per — Cesena, Italy
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.